These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25563521)

  • 1. Clinical relevance of Pseudomonas aeruginosa hypermutation in cystic fibrosis chronic respiratory infection.
    Oliver A
    J Cyst Fibros; 2015 Jul; 14(4):e1-2. PubMed ID: 25563521
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of Pseudomonas aeruginosa hypermutation in cystic fibrosis chronic respiratory infection: Response to Dr. Oliver.
    Bar-Meir M
    J Cyst Fibros; 2015 Jul; 14(4):e3. PubMed ID: 25592655
    [No Abstract]   [Full Text] [Related]  

  • 3. Is infection with hypermutable Pseudomonas aeruginosa clinically significant?
    Auerbach A; Kerem E; Assous MV; Picard E; Bar-Meir M
    J Cyst Fibros; 2015 May; 14(3):347-52. PubMed ID: 25308183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas survival strategies in cystic fibrosis.
    LeClerc JE; Cebula TA
    Science; 2000 Jul; 289(5478):391-2. PubMed ID: 10939947
    [No Abstract]   [Full Text] [Related]  

  • 5. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
    Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
    J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
    Tatnell PJ; Russell NJ; Govan JR; Gacesa P
    Biochem Soc Trans; 1996 Aug; 24(3):406S. PubMed ID: 8878950
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.
    Nguyen D; Singh PK
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8305-6. PubMed ID: 16717189
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystic fibrosis and pseudomonas infection.
    Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis.
    Penketh A; Pitt T; Roberts D; Hodson ME; Batten JC
    Am Rev Respir Dis; 1983 May; 127(5):605-8. PubMed ID: 6405665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ribotypes of strains of Pseudomonas aeruginosa in a patient with cystic fibrosis].
    Ferrús MA; Alonso R; Hernández M; Montes RM; Hernández J
    Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):461-4. PubMed ID: 9918992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
    Høiby N; Johansen HK
    J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.
    Ulrich M; Beer I; Braitmaier P; Dierkes M; Kummer F; Krismer B; Schumacher U; Gräpler-Mainka U; Riethmüller J; Jensen PØ; Bjarnsholt T; Høiby N; Bellon G; Döring G
    Thorax; 2010 Nov; 65(11):978-84. PubMed ID: 20880875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa infection in cystic fibrosis: biosynthesis of alginate as a virulence factor.
    Roychoudhury S; Zielinski NA; DeVault JD; Kato J; Shinabarger DL; May TB; Maharaj R; Kimbara K; Misra TK; Chakrabarty AM
    Antibiot Chemother (1971); 1991; 44():63-7. PubMed ID: 1801646
    [No Abstract]   [Full Text] [Related]  

  • 16. Colonisation of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis.
    Tsang V; Pitt TL; Kaufmann ME; Gaya H; Hodson ME; Yacoub M
    Thorax; 1994 Jul; 49(7):721-2. PubMed ID: 8066572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.
    Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K;
    J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron, Pseudomonas aeruginosa and cystic fibrosis.
    Reid DW; Kirov SM
    Microbiology (Reading); 2004 Mar; 150(Pt 3):516. PubMed ID: 14993297
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Petersen US; Høiby N
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
    Singh M; Yau YCW; Wang S; Waters V; Kumar A
    Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.